Fujian, China

Xin Lian

This inventor holds 1 USPTO granted patent. Top assignee: Fujian Haixi Pharmaceuticals Co., Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Lian. Retrieved from https://idiyas.com/inventor/xin-lian-7tmwl6k5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Xin Lian

Introduction

Xin Lian is a notable inventor based in Fujian, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His work is characterized by a focus on heteroaryl compounds, which have important applications in medical science.

Latest Patents

Xin Lian holds a patent for "Heteroaryl compounds as kinase inhibitor." This patent describes compounds of formula (I) that exhibit activity on a receptor protein tyrosine kinase. The patent also includes details about various substituents such as R, A, Q, Z, X, and W, along with their solvates, hydrates, tautomers, or pharmaceutically acceptable salts.

Career Highlights

Xin Lian is currently employed at Fujian Haixi Pharmaceuticals Co., Ltd. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the advancement of pharmaceutical research and development.

Collaborations

Some of his coworkers include Yan Feng and Ruyong Wang, who collaborate with him on various projects within the company.

Conclusion

Xin Lian's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of kinase inhibitors, highlight the importance of research and development in creating effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…